Skip to main content
Year archive

AROVELLA THERAPEUTICS LIMITED — 2021 filings

All 16 regulatory filings released by AROVELLA THERAPEUTICS LIMITED (ALA) in 2021, sourced directly from the official regulator.

16 Filings
2021 Period
2021 filings (16)
Filing Released Lang
Notification regarding unquoted securities - ALA 7 pages 29.6KB
Share Issue/Capital Change
2021-12-16 English
Change of Director's Interest Notice x 4 8 pages 359.7KB
Director's Dealing
2021-12-16 English
AGM FY21 Presentation 17 pages 2.6MB
AGM Information
2021-12-15 English
Results of Annual General Meeting 2 pages 501.7KB
Declaration of Voting Results & Voting Rights Announcements
2021-12-15 English
Arovella licences novel monoclonal antibody from MD Anderson 32 pages 4.8MB
Capital/Financing Update
2021-12-12 English
R&D Tax Incentive refund received 2 pages 144.9KB
Capital/Financing Update
2021-11-28 English
Notification regarding unquoted securities - ALA 5 pages 27.1KB
Share Issue/Capital Change
2021-11-16 English
Change of Director's Interest Notice 2 pages 266.5KB
Director's Dealing
2021-11-14 English
Notice of Annual General Meeting/Proxy Form 33 pages 759.2KB
AGM Information
2021-11-14 English
Initial Director's Interest Notice 2 pages 235.3KB
Director's Dealing
2021-11-10 English
Application for quotation of securities - ALA 6 pages 27.7KB
Share Issue/Capital Change
2021-11-10 English
Notification regarding unquoted securities - ALA 6 pages 28.4KB
Share Issue/Capital Change
2021-11-10 English
Senior Management Change 2 pages 143.8KB
Board/Management Information
2021-11-09 English
Appointment of Dr Elizabeth Stoner as Non-Executive Director 2 pages 148.1KB
Board/Management Information
2021-11-09 English
Jobkeeper Payments Notification 1 page 31.0KB
Regulatory Filings
2021-11-09 English
Quarterly Appendix 4C and Activities Report 9 pages 672.0KB
Interim / Quarterly Report
2021-10-26 English